Creso Pharma Limited
COPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $7 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $3 | $1 | $1 |
| Inventory | $1 | $6 | $2 | $1 |
| Other Curr. Assets | $0 | $2 | $0 | $0 |
| Total Curr. Assets | $6 | $12 | $10 | $8 |
| Property Plant & Equip (Net) | $10 | $10 | $10 | $10 |
| Goodwill | $3 | $0 | $0 | $0 |
| Intangibles | $0 | $16 | $8 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $14 | $26 | $19 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19 | $38 | $29 | $19 |
| Liabilities | – | – | – | – |
| Payables | $9 | $4 | $0 | $1 |
| Short-Term Debt | $10 | $7 | $0 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $5 | $2 | $2 |
| Total Curr. Liab. | $23 | $16 | $2 | $5 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $11 | $0 | $0 |
| Total NC Liab. | $0 | $11 | $0 | $0 |
| Other Liabilities | $0 | -$11 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $23 | $16 | $2 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $150 | $128 | $110 | $72 |
| Retained Earnings | -$170 | -$127 | -$95 | -$82 |
| AOCI | $15 | $21 | $13 | $24 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$4 | $22 | $28 | $14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19 | $38 | $29 | $19 |
| Net Debt | $9 | $5 | -$7 | -$3 |